The school’s Division of Hematology-Oncology is comprised of a diverse faculty with expertise in every major hematologic and oncology disease. The division has a multi-disciplinary clinic in prostate cancer, lung cancer, breast cancer, gastrointestinal tumors, head and neck cancer, melanoma, testicular, bone marrow transplant, and precision genomics, among others.
Indiana University's Hematology/Oncology Fellowship is one of the oldest programs in the United States, established by Dr. Lawrence Einhorn in 1975. Graduates from IU have a long track of success including two ASCO presidents, one ASH president, four ASCO presidential candidates, and ten faculty who have served as chairs on various ECOG committees. Indiana University has published multiple landmark trials in the areas of lung, colon, bladder, breast, pancreas, ovarian, germ cell tumors, anti-emetics, quality of life, and survivorship. Indiana University is credited with making the previously fatal disseminated testicular cancer the now highly curable disease we see today. Research from IU has also led to FDA approval of six drugs.



Fellows have the opportunity to pursue structured clinical, educational, and research activities in global oncology through the Academic Model Providing Access to Healthcare (AMPATH). AMPATH is a long-standing collaboration between Moi University and Moi Teaching and Referral Hospital (MTRH) in western Kenya and North American institutions led by Indiana University School of Medicine. With the support of Dr. Patrick Loehrer, Distinguished Professor and the IUSCCC Director of the Center for Global Oncology and Health Equity, the building of a partnership in hematology and oncology began in 2005.
The AMPATH Oncology Institute has now grown into one of the most respected and impactful global partnerships in existence, whose goals are to develop and strengthen an oncology workforce, advance global oncology research and provide comprehensive cancer care to patients in western Kenya. Dr. Jennifer Morgan, Indiana University Assistant Professor of Medicine in the Division of Hematology/Oncology, currently serves as AMPATH’s Oncology Team Leader. Dr. Morgan, who lives in Eldoret, Kenya, works closely with partners from Moi/MTRH, conducts breast cancer care and research, and serves as a mentor for fellows and students interested in global health from the IU School of Medicine.